Dormant
COMP · Compass, Inc.
Last analysed ·
Resolved Graded and closed 2026-08-07 at low conviction — the published kill line did not fire. Coverage continued after the close; the read below is dated 2026-09-13 and is not part of the scored record.
Current thesis
Now stretched into a binary ~2026-07-29 Q2 print ($4.0–4.2B guide) with an open NY AG antitrust probe.
Kill line
A weekly close below $11 loses the luxury-demand breakout above the June AG-dip shelf and reopens the ~$9.78 June low; a formal NY AG divestiture/CID demand or a Q2 revenue miss versus the $4.0–4.2B guide is the secondary break.
Pick status
Played out resolved published kill line did not fire How this is scored →Latest analysis and events for COMP —
As of 13 September 2026, the latest FrontierPicks analysis for Compass, Inc. (COMP): Now stretched into a binary ~2026-07-29 Q2 print ($4.0–4.2B guide) with an open NY AG antitrust probe.
Kill line: A weekly close below $11 loses the luxury-demand breakout above the June AG-dip shelf and reopens the ~$9.78 June low; a formal NY AG divestiture/CID demand or a Q2 revenue miss versus the $4.0–4.2B guide is the secondary break.
Most recent dated event on file: — catalyst 4d ago.
Current Thesis
Compass's recovery case rests on Anywhere cost savings protecting quarterly earnings despite weaker housing transactions; delivery against Q3 guidance and recovery of the broken $11 shelf would establish whether that case works. This is a conditional reconstruction: the original breakout thesis already failed when the market's 2026-08-28 weekly close of $10.97 breached its published $11 threshold.
The new evidence is adverse. August existing-home sales declined 2.0% month over month to a seasonally adjusted annual rate of 3.98 million, according to the National Association of Realtors (NAR) release dated 2026-09-10. That extends the transaction weakness described in the August dossier. NAR release
As an interpretation of price structure, the narrative is dead in its original breakout form — the 2026-09-11 adjusted close of $10.51 remains below the shelf lost on 2026-08-28 despite the company's 2026-08-04 earnings beat. The narrower recovery hypothesis requires Q3 revenue of at least $3.85 billion, adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of at least $275 million, and a weekly close above $11 by the Q3 results publication. A weekly close below $9.78 would invalidate that hypothesis first.
Bullish and bearish views on Compass, Inc.
The model's bull view on Compass, Inc. (COMP), in brief: Savings have measurable operating support. The bear view: National transaction weakness extended again. Both cases follow in full.
Bull Case
- Savings have measurable operating support. Compass's 2026-08-04 Q2 release reported revenue of $4.306 billion and adjusted EBITDA of $363 million, above its earlier $310–350 million EBITDA guidance. The release raised the 2026 realized synergy goal to $220 million; actioned savings and realized savings remain different measures.
- Transaction growth survived the acquisition adjustment. The 2026-08-04 release reported Q2 brokerage gross transaction value of $155.2 billion, up 15.9% on a pro forma comparison, and 153,009 transactions, up 7.4% pro forma. These comparisons provide stronger evidence of operating momentum than acquisition-inflated reported growth.
- Cash generation accompanied reported earnings. Compass reported Q2 operating cash flow of $191 million, free cash flow of $180 million and cash of $694 million on 2026-08-04. Those are historical results; the recovery case fails if Q3 misses the stated revenue or EBITDA floors.
Bear Case
- National transaction weakness extended again. NAR's 2026-09-10 release put August existing-home sales down 1.2% year over year as well as down sequentially. This is evidence against a broad housing recovery, although national sales alone do not establish Compass's company-specific Q3 outcome. NAR release
- Management described widespread price reductions. Benzinga's 2026-09-11 report attributed to CEO Robert Reffkin a statement that 42% of listed homes had received price cuts, following his 2026-09-10 CNBC appearance. The article supplies no sampling method or complete measurement window; that percentage cannot establish Compass's transaction growth or realized commission revenue. Benzinga report
- Higher spending competes with savings. On 2026-08-04, Compass raised its full-year non-GAAP operating-expense guidance to $2.75–2.80 billion, including $35 million associated with a July acquisition. A further increase without a corresponding improvement in realized savings would weaken the earnings-conversion case.
Setup & Price Structure
The supplied adjusted market series records a $10.51 close on 2026-09-11, a three-month price increase of 22.4%, and a price 22.6% below its $13.58 trailing-year high. Its 14-period relative strength index was 34.8. These measurements show that the remaining three-month gain coexists with substantial weakness relative to the high; they do not establish a completed base.
The market's former $11 shelf is now the recovery test. The approximately $9.78 June low documented in the earlier coverage supplies the separate recovery hypothesis's research threshold. This does not revise the original thesis's already-triggered $11 invalidation.
Coverage is observable; ownership crowding is not established. The dated analyst record includes Oppenheimer's $18 target and Wells Fargo's $13 target on 2026-08-05, followed by the September CNBC appearance and Benzinga coverage. This small coverage sample cannot support a claim about expanding participation. Current fund flows, short interest and distance above a rising moving average are missing.
Catalyst Calendar (next 30 days)
- 2026-10-13 — September existing-home sales. NAR's published schedule places this release at the end of the next-month window. It supplies the next completed-month transaction comparison after August's decline. NAR calendar
The company-specific test remains Q3 results against the guidance issued on 2026-08-04. A confirmed publication date is unavailable in the evidence reviewed.
Elapsed catalysts
- 2026-09-16 — Federal Reserve decision. The Federal Open Market Committee's official calendar confirms a 2026-09-15–16 meeting. The decision supplies a policy-rate observation; a favorable mortgage-rate response is not assumed. Federal Reserve calendar (passed 4d ago)
- 2026-09-17 — August pending home sales. NAR's published schedule confirms this release. It tests whether contract signings improved after July's index reading of 71.2, reported on 2026-08-18; another decline would weaken the volume-recovery component. NAR calendar (passed 3d ago)
What Would Change Our Mind
Loss of the June low would end the conditional recovery case: a weekly close below $9.78 is the price invalidation. Q3 revenue below $3.85 billion or adjusted EBITDA below $275 million would independently contradict the operating case, using the lower bounds of Compass's 2026-08-04 guidance.
Positive resolution requires both reported delivery against those floors and a weekly close above the former $11 shelf by the Q3 results publication. Delivery without price recovery would leave the stated recovery case unmet; a price rebound without delivery would leave its earnings explanation unsupported.
Correlation Notes
This is a single-company recovery hypothesis, with housing activity as a proposed economic transmission channel. Compass's 2026-08-04 disclosure of 7.4% pro forma transaction growth and NAR's 2026-09-10 report of declining national sales show why company execution and industry volume require separate measurement. No matched peer-return series is available, so a measured correlation with homebuilders, property technology companies or interest rates cannot be stated.
Notes
- Headline YoY growth is inflated by the 2026-01-09 Anywhere close - organic momentum reads on pro forma figures (Brokerage GTV +15.9% pro forma vs +98.2% reported in Q2).
- The New York AG antitrust inquiry opened 2026-06-03 remains open, with no timetable and no publicly disclosed civil investigative demand.
- CEO-affiliated trusts sell under a Rule 10b5-1 plan adopted 2026-03-03; recurring Form 4 sales are pre-scheduled rather than discretionary.
- Company stated intent to redeem the $500M 9.75% notes when first callable in Q2 2027 - the interest-expense step-down is a 2027 event.
- Revenue is volume-driven: existing-home-sales transaction counts and the mortgage path matter more than home-price levels.
- Compass's antitrust suit against Zillow over listing standards continues; a preliminary injunction was denied in February 2026 and no merits date is public.
Related · shared themes
CXW
CoreCivic, Inc.
CoreCivic's facility sales support a real-estate monetization thesis; another completed sale by third-quarter results must confirm its next leg while operating contracts remain intact. A weekly close below $31 invalidates the price thesis.
HNI
HNI Corporation
HNI Corporation’s Steelcase integration could sustain earnings growth despite weak organic sales, but the September 18 close broke the prior shelf. The next quarterly report tests delivery against July’s raised outlook; a weekly close below $44 ends the market re-rating thesis.
BXC
BlueLinx Holdings Inc.
BlueLinx's specialty-margin re-rating depends on Trex execution and price repair. Completed initial stocking followed by a weekly close above $84 would resolve the recovery case; a weekly close below $72 would invalidate it.
FLXS
Flexsteel Industries, Inc.
Flexsteel Industries’ operating-turnaround thesis requires a weekly close above $84.20 before a weekly close below $79.69. These are the high and reference close in the September 18, 2026 market snapshot; weaker quarterly margins limit confidence in continuation.